Table 2 Comparison of the mean percentage of positive cells for VEGF, NF-κB, PCNA, MMP-2 and MMP-9 expression between the treatment group and the control group ( ± SD)
From: Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
Control (n = 15) | Experimental (n = 15) | t | P | |
|---|---|---|---|---|
VEGF | 18.34 ± 2.32 | 13.67 ± 2.51 | 3.47 | 0.004 |
NF-κB | 17.92 ± 4.45 | 12.21 ± 2.84 | 3.05 | 0.009 |
MMP-2 | 24.06 ± 3.92 | 10.93 ± 3.35 | 2.36 | 0.000 |
MMP-9 | 19.32 ± 3.66 | 10.46 ± 3.76 | 2.31 | 0.002 |
PCNA | 80.94 ± 4.90 | 67.55 ± 7.75 | 2.18 | 0.002 |